Joshua Harris writes for European Pharmaceutical Review
- Patent & IP
![](/media/hftflsyo/joshua-harris-2021_12_burford-capital_group-2_0737_bw.jpg?width=520&height=390&v=1d9f3460b498c50)
Joshua Harris writes for European Pharmaceutical Review about how patent monetization, including systems like the Unified Patent Court (UPC), enables European pharmaceutical companies to remain competitive and ensure R&D investment and innovation.